BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9059560)

  • 21. Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy.
    Oscarsson J; Wiklund O; Jakobsson KE; Petruson B; Bengtsson BA
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):603-8. PubMed ID: 7828349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly.
    Parkinson C; Drake WM; Wieringa G; Yates AP; Besser GM; Trainer PJ
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):303-11. PubMed ID: 11940041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proinsulin, intact insulin, and fibrinolytic variables and fibrinogen in healthy subjects. A population study.
    Eliasson M; Røder ME; Dinesen B; Evrin PE; Lindahl B
    Diabetes Care; 1997 Aug; 20(8):1252-5. PubMed ID: 9250449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse anthropometric risk profile in biochemically controlled acromegalic patients: comparison with an age- and gender-matched primary care population.
    Dimopoulou C; Sievers C; Wittchen HU; Pieper L; Klotsche J; Roemmler J; Schopohl J; Schneider HJ; Stalla GK
    Pituitary; 2010 Sep; 13(3):207-14. PubMed ID: 20131100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.
    Colao A; Spiezia S; Cerbone G; Pivonello R; Marzullo P; Ferone D; Di Somma C; Assanti AP; Lombardi G
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):515-24. PubMed ID: 11318788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperinsulinemia predicts low tissue plasminogen activator activity in a healthy population: the Northern Sweden MONICA Study.
    Eliasson M; Asplund K; Evrin PE; Lindahl B; Lundblad D
    Metabolism; 1994 Dec; 43(12):1579-86. PubMed ID: 7990715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor I.
    Wildbrett J; Hanefeld M; Fücker K; Pinzer T; Bergmann S; Siegert G; Breidert M
    Exp Clin Endocrinol Diabetes; 1997; 105(6):331-5. PubMed ID: 9439928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
    Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone secretion in recently operated acromegalic patients.
    van den Berg G; Frölich M; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1706-15. PubMed ID: 7989479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.
    Attanasio R; Epaminonda P; Motti E; Giugni E; Ventrella L; Cozzi R; Farabola M; Loli P; Beck-Peccoz P; Arosio M
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3105-12. PubMed ID: 12843150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Octreotide as primary therapy for acromegaly.
    Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor 1 and insulin levels in various insulin resistance states.
    Scelles V; Raccah D; Alessi MC; Vialle JM; Juhan-Vague I; Vague P
    Diabete Metab; 1992; 18(1):38-42. PubMed ID: 1563535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
    Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
    Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
    Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
    J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity.
    Kaltsas GA; Isidori AM; Florakis D; Trainer PJ; Camacho-Hubner C; Afshar F; Sabin I; Jenkins JP; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1645-52. PubMed ID: 11297598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of fibrinogen and CRP in cardiovascular risk in patients with acromegaly.
    Kałuzny M; Bolanowski M; Daroszewski J; Szuba A
    Endokrynol Pol; 2010; 61(1):83-8. PubMed ID: 20205109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of cigarette smoking and snuff dipping to plasma fibrinogen, fibrinolytic variables and serum insulin. The Northern Sweden MONICA Study.
    Eliasson M; Asplund K; Evrin PE; Lundblad D
    Atherosclerosis; 1995 Feb; 113(1):41-53. PubMed ID: 7755654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly.
    Dobrashian RD; O'Halloran DJ; Hunt A; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1993 Jun; 38(6):589-93. PubMed ID: 8334745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.